您的位置: 首页 > 农业专利 > 详情页

CRYSTALLINE FORMS OF A JAK INHIBITOR COMPOUND
专利权人:
THERAVANCE BIOPHARMA R and D IP; LLC
发明人:
DABROS, Marta,THALLADI, Venkat R.,NZEREM, Jerry,KLEINSCHEK, Melanie A.,CRATER, Glenn D.
申请号:
PH12019502425
公开号:
PH12019502425A1
申请日:
2019.10.25
申请国别(地区):
PH
年份:
2020
代理人:
摘要:
The present invention provides crystalline hydrates of the oxalate and succinate salts of 5-ethyl-2-fluoro-4-(3-(5-(1-methylpiperidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-6-yl)phenol. The invention also provides pharmaceutical compositions comprising such crystalline hydrates, methods of using such crystalline hydrates to treat respiratory and other diseases, and processes useful for preparing such crystalline oxalate and succinate hydrates.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充